Paid Clinical Trials in Providence, RI

As of September 2026, 420 paid clinical trials are recruiting in Providence, Rhode Island. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

374 clinical trials

Get a weekly email when new trials open in Providence, RI.

The Ailliance Post-Market Clinical Study

for Spinal Deformity

Sites in Providence +21 more locations

Sponsor: Medtronic Spinal and Biologics

Sex: All·Age: 18+

Code: NCT05856370·Recruiting·Listed May 2023

Apply to this trial

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Providence +13 more locations

Sponsor: Debiopharm International SA

Sex: All·Age: 12+

Code: NCT04855656·Phase 1·Recruiting·Listed Apr 2021

Apply to this trial

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

for Central Line Associated Blood Stream Infections (CLABSI)

Sites in Providence +15 more locations

Sponsor: CorMedix Therapeutics

Sex: All·Age: 18+

Code: NCT06822426·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

for Relapsed/Refractory Non-Hodgkin Lymphoma

Sites in Providence +9 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06090539·Phase 1, Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

WRAP North America

for Venous Stenosis

Sites in Providence +12 more locations

Sponsor: Merit Medical Systems, Inc.

Sex: All·Age: 18+

Code: NCT06807099·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for Solid Tumors

Sites in Providence +10 more locations

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT05836324·Phase 1·Recruiting·Listed May 2023

Apply to this trial

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Drug: Cemiplimab

Sites in Providence +22 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT03972657·Phase 1, Phase 2·Recruiting·Listed Jun 2019

Apply to this trial

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Providence +13 more locations

Sponsor: Eikon Therapeutics

Sex: All·Age: 18 - 89

Code: NCT06253130·Phase 1, Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

A Study of PYX-201 in Advanced Solid Tumors

for Solid Tumor

Sites in Providence +16 more locations

Sponsor: Pyxis Oncology, Inc

Sex: All·Age: 18+

Code: NCT05720117·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

Pilot/Pivotal Study of DBS+Rehab After Stroke

for Stroke

Sites in Providence +8 more locations

Sponsor: Enspire DBS Therapy, Inc.

Sex: All·Age: 21+

Code: NCT05701280·Recruiting·Listed Jan 2023

Apply to this trial

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

for Advanced Solid Tumors Cancer

Sites in Providence +9 more locations

Sponsor: Nimbus Wadjet, Inc.

Sex: All·Age: 18 - 99

Code: NCT06898450·Phase 1, Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

for Advanced Solid Tumor Cancer

Drug: ABBV-CLS-484

Sites in Providence +12 more locations

Sponsor: Calico Life Sciences LLC

Sex: All·Age: 18+

Code: NCT04777994·Phase 1·Recruiting·Listed Mar 2021

Apply to this trial

Study of SGR-1505 in Mature B-Cell Neoplasms

for Mature B-Cell Neoplasm

Sites in Providence +15 more locations

Sponsor: Schrödinger, Inc.

Sex: All·Age: 18+

Code: NCT05544019·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma

Sites in Providence +14 more locations

Sponsor: Bicara Therapeutics

Sex: All·Age: 18+

Code: NCT04429542·Phase 1·Recruiting·Listed Jun 2020

Apply to this trial

Clinical Trial on Agitation in Alzheimer's Dementia

for Alzheimer Disease

Sites in Providence +21 more locations

Sponsor: IGC Pharma, LLC

Sex: All·Age: 60+

Code: NCT05543681·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Serranator POINT FORCE Registry

for Peripheral Artery Disease (PAD)

Sites in Providence +17 more locations

Sponsor: Cagent Vascular LLC

Sex: All·Age: 18+

Code: NCT06687590·Recruiting·Listed Nov 2024

Apply to this trial

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

for Advanced Solid Tumor

Sites in Providence +12 more locations

Sponsor: Volastra Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05902988·Phase 1, Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

for NHL

Sites in Providence +8 more locations

Sponsor: Indapta Therapeutics, INC.

Sex: All·Age: 18+

Code: NCT06119685·Phase 1, Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis

for Primary Sclerosing Cholangitis

Drug: Elafibranor

Sites in Providence +12 more locations

Sponsor: Ipsen

Sex: All·Age: 18 - 75

Code: NCT07387549·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

for Pulmonary Hypertension

Sites in Providence +12 more locations

Sponsor: Pulmovant, Inc.

Sex: All·Age: 18 - 85

Code: NCT07333183·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

for Lymphoma Diffuse Large B-cell

Sites in Providence +4 more locations

Sponsor: AvenCell Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07284433·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

for Metastatic Castration-Resistant Prostate Cancer

Sites in Providence +5 more locations

Sponsor: Hoffmann-La Roche

Sex: Male·Age: 18+

Code: NCT07287150·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

for Glioblastoma

Sites in Providence +8 more locations

Sponsor: GT Medical Technologies, Inc.

Sex: All·Age: 18+

Code: NCT07195591·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Providence +3 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT05765851·Phase 1·Recruiting·Listed Mar 2023

Apply to this trial

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

for Sickle Cell Disease

Sites in Providence +6 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 12 - 55·Accepts healthy volunteers

Code: NCT06546670·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

for Brain Tumor

Sites in Providence +7 more locations

Sponsor: InSightec

Sex: All·Age: 18 - 100

Code: NCT05317858·Phase 3·Recruiting·Listed Apr 2022

Apply to this trial

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

for Acute Myeloid Leukaemia (AML)

Sites in Providence +7 more locations

Sponsor: Moleculin Biotech, Inc.

Sex: All·Age: 18 - 80

Code: NCT06788756·Phase 2, Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Providence +6 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT05875168·Phase 1, Phase 2·Recruiting·Listed May 2023

Apply to this trial

Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

for Pulmonary Hypertension

1 location in Providence

Sponsor: Eko Devices, Inc.

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05873387·Recruiting·Listed May 2023

Apply to this trial

A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

for Solid Tumor

Sites in Providence +4 more locations

Sponsor: Chugai Pharmaceutical

Sex: All·Age: 18+

Code: NCT05907980·Phase 1·Recruiting·Listed Jun 2023

Apply to this trial

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for Gynecologic Cancers

Sites in Providence +7 more locations

Sponsor: AbbVie

Sex: Female·Age: 18+

Code: NCT07024784·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

for Advanced or Metastatic Adrenocortical Carcinoma

Sites in Providence +2 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT07189403·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for Solid Tumor

Sites in Providence +8 more locations

Sponsor: Sanofi

Sex: All·Age: 18+

Code: NCT05584670·Phase 1, Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Providence +3 more locations

Sponsor: Peel Therapeutics Inc

Sex: All·Age: 18+

Code: NCT05329103·Phase 1·Recruiting·Listed Apr 2022

Apply to this trial

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

for Advanced Cancer

Drug: Ipilimumab

Sites in Providence +3 more locations

Sponsor: 7 Hills Pharma, LLC

Sex: All·Age: 18+

Code: NCT06362369·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

for Locally Advanced Pancreatic Adenocarcinoma

Sites in Providence +6 more locations

Sponsor: EXACT Therapeutics AS

Sex: All·Age: 18+

Code: NCT06850623·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

for Depressive Disorder, Major

Sites in Providence +1 more location

Sponsor: GrayMatters Health Ltd.

Sex: All·Age: 22 - 75

Code: NCT06982820·Recruiting·Listed May 2025

Apply to this trial

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

for Endometrial Cancer

Sites in Providence +8 more locations

Sponsor: Aadi Bioscience, Inc.

Sex: All·Age: 18+

Code: NCT05997017·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

for Recurrent Head and Neck Squamous Cell Carcinoma

Sites in Providence +6 more locations

Sponsor: Rakuten Medical, Inc.

Sex: All·Age: 18+

Code: NCT06699212·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas

for Anal Fistula

Sites in Providence +7 more locations

Sponsor: RedDress Ltd.

Sex: All·Age: 18+

Code: NCT05641844·Recruiting·Listed Dec 2022

Apply to this trial